The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Histamine and its receptors
Open accessAbstract
This article reviews the development of our knowledge of the actions of histamine which have taken place during the course of the 20th century. Histamine has been shown to have a key physiological role in the control of gastric acid secretion and a pathophysiological role in a range of allergic disorders. The synthesis of, and pharmacological studies on, selective agonists and antagonists has established the existence of four types of histamine receptor and histamine receptor antagonists have found very important therapeutic applications. Thus, in the 1940s, H 1‐receptor antagonists (‘the antihistamines’) yielded and still provide valuable treatment for allergic conditions such as hay fever and rhinitis. In the late 1970s and 1980s, H 2‐receptor antagonists (in the discovery of which the two authors were personally involved) revolutionised the treatment of peptic ulcer and other gastric acid‐related diseases. The H 3‐receptor antagonists, although available since 1987, have been slower to find a therapeutic role. However, the discovery of nonimidazole derivatives such as brain‐penetrating H 3 antagonists has provided drugs that are in early‐phase clinical trials, possibly for application in obesity, and a variety of central nervous system disorders, such as memory, learning deficits and epilepsy. Finally, the most recently (1999) discovered H 4 receptor promises the potential to provide drugs acting on the immunological system with possible applications in asthma and inflammation. British Journal of Pharmacology(2006)147, S127–S135. doi:10.1038/sj.bjp.0706440
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and Antagonism of Histamine H2-receptors
BLACK, J. W., DUNCAN, W. A. M., DURANT, C. J., GANELLIN, C. R., & PARSONS, E. M. (1972) · Nature · doi:10.1038/236385a0 · Cited by 2,259
Self-citationHighly potent and selective ligands for histamine H3-receptors
Arrang, J.-M., Garbarg, M., Lancelo, J.-C., Lecomte, J.-M., Pollard, H., Robba, M., Schunack, W., & Schwartz, J.-C. (1987) · Nature · doi:10.1038/327117a0 · Cited by 903
International Union of Pharmacology. XIII. Classification of Histamine Receptors
Hill, S. J., Ganellin, C. R., Timmerman, H., Schwartz, J. C., Shankley, N. P., Young, J. M., Schunack, W., Levi, R., & Haas, H. L. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01328-0 · Cited by 899
Self-citationThe physiological action of β‐iminazolylethylamine
Dale, H. H., & Laidlaw, P. P. (1910) · The Journal of Physiology · doi:10.1113/jphysiol.1910.sp001406 · Cited by 884
Watanabe, T., Taguchi, Y., Shiosaka, S., Tanaka, J., Kubota, H., Terano, Y., Tohyama, M., & Wada, H. (1984) · Brain Research · doi:10.1016/0006-8993(84)90811-4 · Cited by 820
RECEPTORS MEDIATING SOME ACTIONS OF HISTAMINE
ASH, A. S. F., & SCHILD, H. O. (1966) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1966.tb01674.x · Cited by 758
pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM
SCHILD, H. O. (1947) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1947.tb00336.x · Cited by 754
Comprehensive Medicinal Chemistry
(1991) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19910100410 · Cited by 745
Cloning and Functional Expression of the Human Histamine H3Receptor
Lovenberg, T. W., Roland, B. L., Wilson, S. J., Jiang, X., Pyati, J., Huvar, A., Jackson, M. R., & Erlander, M. G. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1101 · Cited by 696
The histamine H3 receptor: from gene cloning to H3 receptor drugs
Leurs, R., Bakker, R. A., Timmerman, H., & de Esch, I. J. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1631 · Cited by 485
High constitutive activity of native H3 receptors regulates histamine neurons in brain
Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C. R., & Arrang, J.-M. (2000) · Nature · doi:10.1038/35048583 · Cited by 461
Self-citationPharmacology of Histamine Receptors
(1982) · Elsevier eBooks · doi:10.1016/c2013-0-06452-3 · Cited by 376
Genomics Meets Histamine Receptors: New Subtypes, New Receptors
Hough, L. B. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12229-8 · Cited by 314
The nature of the vaso‐dilator constituents of certain tissue extracts
Best, C. H., Dale, H. H., Dudley, H. W., & Thorpe, W. V. (1927) · The Journal of Physiology · doi:10.1113/jphysiol.1927.sp002369 · Cited by 245
Histamine as a transmitter in brain
Schwartz, J.-C. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90083-1 · Cited by 211
β-imidazolyläthylamin und die Organextrakte
Popielski, L. (1920) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf01722024 · Cited by 159
Histamine in Tissue Mast Cells
RILEY, J. F. (1953) · Science · doi:10.1126/science.118.3064.332 · Cited by 155
Ligneau, X., Morisset‐Lopez, S., Tardivel‐Lacombe, J., Gbahou, F., Ganellin, C. R., Stark, H., Schunack, W. G., Schwartz, J., & Arrang, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703712 · Cited by 147
Self-citationHistamine and Gastric Secretion
Code, C. F. (1966) · Gastroenterology · doi:10.1016/s0016-5085(19)34425-7 · Cited by 105
Shin, N., Coates, E., Murgolo, N., Morse, K. L., BAYNE, M. L., Strader, C. D., & Monsma, F. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.38 · Cited by 92
Folkow, B., HJEGER, K., & Kahlson, G. (1948) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1948.tb00503.x · Cited by 90
Histamine and Gastric Secretion
Code, C. F. (1956) · Novartis Foundation symposium · doi:10.1002/9780470718957.ch25 · Cited by 81
Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings].
Bradshaw, J., Rt, B., Clitherow, J. W., et al. (1979) · PubMed · Cited by 74
The pharmacology of cimetidine, a new histamine H2‐receptor antagonist
Rw, B., Duncan, W. A. M., Durant, G., Ganellin, C. R., Parsons, M., & Black, J. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00854.x · Cited by 74
Self-citation6 The Histamine H3 Receptor and its Ligands
Stark, H., Arrang, J., Ligneau, X., Garbarg, M., Ganellin, C. R., Schwartz, J., & Schunack, W. G. (2001) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70096-1 · Cited by 47
Self-citationTHE ACTION OF HISTAMINE ON HYDROCHLORIC ACID AND PEPSIN SECRETION IN MAN
Ashford, C. A., Heller, H., & Smart, G. (1949) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1949.tb00528.x · Cited by 22
Cited by
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826
TRPA1 is required for histamine-independent, Mas-related G protein–coupled receptor–mediated itch
Wilson, S. R., Gerhold, K. A., Bifolck-Fisher, A., Liu, Q., Patel, K. N., Dong, X., & Bautista, D. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2789 · Cited by 599
Thangam, E. B., Jemima, E. A., Singh, H., Baig, M. S., Khan, M., Mathias, C. B., Church, M. K., & Saluja, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01873 · Cited by 534
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Kumar, P., Shen, Q., Pivetti, C. D., Lee, E. S., Wu, M. H., & Yuan, S. Y. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001112 · Cited by 380
Metadata
- Authors
- Parsons, M. E., & Ganellin, C. R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S127-35
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2123026925
- Cited by
- 556
- References
- 26
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.